CP improved glucose homeostasis through regulating gut microbiota, while the anti-NAFLD effect of CP mainly relied on activated FAO by increasing the nuclear localization of PPARα and the expression of CPT1α. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.